Tracy Lynnette Yarbrough, M.D., Ph.D., M.A.Ed. for UC Davis Health

Tracy Lynnette Yarbrough, M.D., Ph.D., M.A.Ed.

Associate Chair, Diversity, Equity and Inclusion

Director, Nuclear Medicine Fellowship

Director, Nuclear Medicine/Diagnostic Radiology Residency Program

International Medical Graduates Program Director

Clinical Professor, Department of Radiology

To see if Tracy Lynnette Yarbrough is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).



Nuclear Medicine



Locations and Contact

UC Davis Medical Center

UC Davis Medical Center
2315 Stockton Blvd.
Sacramento, CA 95817

Get Directions

Additional Numbers

Physician Referrals

800-4-UCDAVIS (800-482-3284)

Philosophy of Care

Dr. Yarbrough's philosophy is to approach each patient and their health with individualized care and compassion.

Clinical Interests

Dr. Yarbrough is a clinical nuclear medicine physician offering the gamut of diagnostic and therapeutic nuclear medicine and molecular imaging procedures. She has special clinical interest and expertise in nuclear cardiology.

Research/Academic Interests

Dr. Yarbrough's research focuses on the development and assessment of critical reasoning at all levels of medical education, with particular emphasis on educational equity and human development. In addition, she is also interested in the use of noninvasive imaging to examine the intersections between inflammation, neurodegenerative and cardiovascular diseases.


Nuclear Medicine

Undergraduate School

B.S., Biomedical Engineering, University of Southern California, Los Angeles CA 1995

Medical School

M.D., University of Iowa Carver College of Medicine, Iowa City IA 2004

Other School

M.A.Ed., Education and Human Development, George Washington University, Washington DC 2017

Other School

Ph.D., Physiology and Biophysics, University of Iowa Carver College of Medicine, Iowa City IA 2004


Family Medicine, Broadlawns Medical Center, Des Moines IA 2004-2005


Nuclear Medicine, Johns Hopkins Hospital, Baltimore MD 2005-2007

M2 Teacher of the Year, California Northstate University College of Medicine, 2021

Hyman-Ghesani RAD-AID SMNNI Global Health Scholarship, Aga Khan Hospital—Dar es Salaam (Tanzania), 2018

Fellowship, American College of Nuclear Medicine (ACNM), 2018

President’s Award, American College of Nuclear Medicine (ACNM), 2017

Yarbrough, TL. An Overview of Nuclear Medicine in the Assessment of Infection and Inflammation. Radiology Resident Core Curriculum Lecture Series. 2021. Available online at: 

Kile S, Au W, Parise C, Sohi J, Yarbrough T, Czeszynski A, Johnson K, Redline D, Donnel T, Hankins A, Rose K. Reduction of Amyloid in the Brain and Retina After Treatment With IVIG for Mild Cognitive Impairment. Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317519899800. doi:10.1177/1533317519899800. PMID:32048858.

Komarraju A, Bartel TB, Dickinson LA, Grant FD, Yarbrough TL. Implementation of a Flipped Classroom for Nuclear Medicine Physician CME. J Contin Educ Health Prof. 2018 Summer;38(3):198-204. doi:10.1097/CEH.0000000000000204. PMID:29933263.

Bartel TB, Yarbrough TL, Antoniou A, Flynt L, Ahmed R, Alfaham Z, Cohen E, Jafari L, Marcus C, Ram R, Subramanian R. ACNM Education Committee. QEVLAR NucCore Question Bundle, Montpellier, France: IMAIOS SAS. Original publication 2015; Most recent update 16 November, 2018 with authors Bartel TB, Odom C, Yarbrough TL, Cohen EJ, Flynt L, Osmany S, Wachsmann J, Ahmed R, Alfaham Z, Jafari L, Marcus C, Ram R, Subramanian  R). Available online at:

Alapati S, Bartel TB, Hoque KE. ACNM-SNMMI Online MRI Case Review: Abdominal Part 1. Bartel TB, Osmany S, Yarbrough TL (Eds). Soc Nuclear Med Molecular Imaging. 2016 Aug.

Johnston MJ, Ntambi JA, Hilliard N, Spencer HJ, Vaughn R, Owens SS, Myrick RS, Parker LD, Garner DA, Yarbrough TL. Reducing perceived pain levels during nonbreast lymphoscintigraphy. Clin Nucl Med. 2015 Dec;40(12):945-9. doi:10.1097/RLU.0000000000000905. PMID:26222533.

Han EY, Lee C, Mcguire L, Brown TL, Bolch WE. Organ S values and effective doses for family members exposed to adult patients following I-131 treatment: a Monte Carlo simulation study. Med Phys. 2013 Aug;40(8):083901. doi:10.1118/1.4812425. PMID:23927361.

Usmani SZ, Mitchell A, Waheed S, Crowley J, Hoering A, Petty N, Brown T, Bartel T, Anaissie E, van Rhee F, Barlogie B. Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3. Blood. 2013 Mar 7;121(10):1819-23. doi:10.1182/blood-2012-08-451690. Epub 2013 Jan 10. PMID:23305732.

Waheed S, Mitchell A, Usmani S, Epstein J, Yaccoby S, Nair B, van Hemert R, Angtuaco E, Brown T, Bartel T, McDonald J, Anaissie E, van Rhee F, Crowley J, Barlogie B. Standard and novel imaging methods for multiple myeloma: correlates with prognostic laboratory variables including gene expression profiling data. Haematologica. 2013 Jan;98(1):71-8. doi:10.3324/haematol.2012.066555. Epub 2012 Jun 24. PMID:22733020.

Brown TL, Spencer HJ, Beenken KE, Alpe TL, Bartel TB, Bellamy W, Gruenwald JM, Skinner RA, McLaren SG, Smeltzer MS. Evaluation of dynamic [18F]-FDG-PET imaging for the detection of acute post-surgical bone infection. PLoS One. 2012;7(7):e41863. doi:10.1371/journal.pone.0041863. Epub 2012 Jul 30. PMID:22860021.